Clin Exp Otorhinolaryngol.  2011 Mar;4(1):52-54.

Otologic Manifestation in IgG4-Related Systemic Disease

Affiliations
  • 1Department of Otorhinolaryngology, National Medical Center, Seoul, Korea.
  • 2Department of Rheumatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • 3Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • 4Department of Otorhinolaryngology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. jwkoo99@snu.ac.kr
  • 5Sensory Organ Research Institute, Seoul National University Medical Research Center, Seoul, Korea.

Abstract

IgG4-related systemic disease, including autoimmune pancreatitis, is a multi-organ disorder characterized by elevated serum immunoglobulin G4 (IgG4) concentration and IgG4-positive plasma cell infiltration. We report a case of a 66-year-old woman with IgG4-related hearing disorder, presenting with fluctuating mixed hearing loss with middle ear effusion. The serum IgG4 level was elevated and pathological examination revealed dense infiltration of IgG4-positive lymphocyte in the renal parenchyma, lung tissue and lacrimal gland. With intravenous methylprednisolone at a dose of 60 mg daily, improvement of hearing loss were observed. No recurrence was observed for 6 months with mainternance of prednisolone and methotrexate.

Keyword

Immunoglobulin G; Hearing loss; Autoimmune disease

MeSH Terms

Aged
Autoimmune Diseases
Female
Hearing Disorders
Hearing Loss
Hearing Loss, Mixed Conductive-Sensorineural
Humans
Immunoglobulin G
Immunoglobulins
Lacrimal Apparatus
Lung
Lymphocytes
Methotrexate
Methylprednisolone
Otitis Media with Effusion
Pancreatitis
Plasma Cells
Prednisolone
Recurrence
Immunoglobulin G
Immunoglobulins
Methotrexate
Methylprednisolone
Prednisolone

Figure

  • Fig. 1 Change of hearing according to the immunosuppressive treatment. Black bars at the top indicate the period of immunosuppressive therapy.

  • Fig. 2 Immunoglobulin G4 (IgG4) immunoreactivity in lacrimal gland. Note strong immunoreactivity for IgG4 in the cytoplasm of infiltrated lymphocytes and plasma cells (×400).


Reference

1. Bovo R, Aimoni C, Martini A. Immune-mediated inner ear disease. Acta Otolaryngol. 2006; 10. 126(10):1012–1021. PMID: 16923703.
Article
2. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003; 38(10):982–984. PMID: 14614606.
Article
3. Saeki T, Saito A, Hiura T, Yamazaki H, Emura I, Ueno M, et al. Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease. Intern Med. 2006; 45(3):163–167. PMID: 16508232.
Article
4. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008; 7. 07. 14(25):3948–3955. PMID: 18609677.
Article
5. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 3. 344(10):732–738. PMID: 11236777.
Article
6. Rauch SD, Ruckenstein MJ. Cummings CS, Haughey BH, Thomas JR, Harker LA, Flint PW, editors. Autoimmune inner-ear disease. Cummings otolaryngology: head and neck surgery. 2005. 4th ed. Philadelphia (PA): Elsevier Mosby;p. 2926–2933.
Full Text Links
  • CEO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr